AAAAAA

   
Results: 1-9 |
Results: 9
Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation
Authors: Bubalo, Y Seelig, F Karbowicz, S Maziarz, RT
Citation: Y. Bubalo et al., Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation, BIOL BLOOD, 7(8), 2001, pp. 439-445
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens
Authors: Gutierrez-Delgado, F Maloney, DG Press, OW Golden, J Holmberg, LA Maziarz, RT Hooper, H Buckner, CD Appelbaum, FR Bensinger, WI
Citation: F. Gutierrez-delgado et al., Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens, BONE MAR TR, 28(5), 2001, pp. 455-461
Specific immunotherapy for non-Hodgkin's lymphoma
Authors: Leis, JF Maziarz, RT
Citation: Jf. Leis et Rt. Maziarz, Specific immunotherapy for non-Hodgkin's lymphoma, LAB MED, 32(10), 2001, pp. 609-616
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria
Authors: Araten, DJ Swirsky, D Karadimitris, A Notaro, R Nafa, K Bessler, M Thaler, HT Castro-Malaspina, H Childs, BH Boulad, F Weiss, M Anagnostopoulos, N Kutlar, A Savage, DG Maziarz, RT Jhanwar, S Luzzatto, L
Citation: Dj. Araten et al., Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria, BR J HAEM, 115(2), 2001, pp. 360-368
High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer
Authors: Gutierrez-Delgado, F Holmberg, LA Hooper, H Appelbaum, FR Livingston, RB Maziarz, RT Weiden, P Rivkin, S Montgomery, P Kawahara, K Bensinger, W
Citation: F. Gutierrez-delgado et al., High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer, BONE MAR TR, 26(1), 2000, pp. 51-59
Transplantation of CD34(+) peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial
Authors: Yanovich, S Mitsky, P Cornetta, K Maziarz, RT Rosenfeld, C Krause, DS Lotz, JP Bitran, JD Williams, B Preti, R Somlo, G Burtness, B Mills, B
Citation: S. Yanovich et al., Transplantation of CD34(+) peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial, BONE MAR TR, 25(11), 2000, pp. 1165-1174
Mechanical ventilation in hematopoietic stem cell transplant patients - Isthere need for reevaluation?
Authors: Nichols, DJ Maziarz, RT Haupt, MT
Citation: Dj. Nichols et al., Mechanical ventilation in hematopoietic stem cell transplant patients - Isthere need for reevaluation?, CHEST, 116(4), 1999, pp. 857-859
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
Authors: Holmberg, LA Boeckh, M Hooper, H Leisenring, W Rowley, S Heimfeld, S Press, O Maloney, DG McSweeney, P Corey, L Maziarz, RT Appelbaum, FR Bensinger, W
Citation: La. Holmberg et al., Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation, BLOOD, 94(12), 1999, pp. 4029-4035
Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2
Authors: Guo, H Tittle, TV Allen, H Maziarz, RT
Citation: H. Guo et al., Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2, EXP CELL RE, 245(1), 1998, pp. 57-68
Risultati: 1-9 |